Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −26 $226.82 $6K 15,286
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −96 $228.30 $22K 15,190
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −198 $229.06 $45K 14,992
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −227 $229.93 $52K 14,765
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −74 $231.59 $17K 14,691
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −161 $232.54 $37K 14,530
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −86 $233.53 $20K 14,444
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −138 $234.66 $32K 14,306
2024-06-25 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −125 $235.19 $29K 14,181
2024-06-24 PYOTT DAVID E I Director Exercise or conversion 10b5-1 +17,560 $88.95 $1.6M 17,696
2024-06-24 PYOTT DAVID E I Director Exercise or conversion 10b5-1 +7,420 $70.20 $521K 25,116
2024-06-24 PYOTT DAVID E I Director Exercise or conversion 10b5-1 +7,470 $71.99 $538K 32,586
2024-06-24 PYOTT DAVID E I Director Sale 10b5-1 −17,560 $220.00 $3.9M 15,026
2024-06-24 PYOTT DAVID E I Director Sale 10b5-1 −7,420 $221.00 $1.6M 7,606
2024-06-24 PYOTT DAVID E I Director Sale 10b5-1 −7,470 $222.00 $1.7M 136
2024-06-24 PYOTT DAVID E I Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −7,420 3,830
2024-06-24 PYOTT DAVID E I Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −7,470 3,780
2024-06-24 PYOTT DAVID E I Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −17,560 7,440
2024-06-24 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award +4,295 17,712
2024-06-24 Greenstreet Yvonne Chief Executive Officer Grant or award +16,953 88,835

Page 46 of 80 · 1,590 trades